Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?

Lung

Volumn 194, Issue 2, 2016, Pages 249-257

  Pleguezuelos, Eulogio ^a,b,c   Esquinas, Cristina ^d   Moreno, Eva ^e   Guirao, Lluis ^a   Ortiz, Javier ^f   Garcia Alsina, Joan ^f   Merí, Alex ^b,c   Miravitlles, Marc ^d  

^a Hospital of Mataro   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITAT RAMON LLULL   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Hospitalet   (Spain)

^f Biomechanics Laboratory   (Spain)

Author keywords

COPD; Deconditioning; Inflammatory markers; Muscle function

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

6 MINUTE WALKING TEST; AGED; ARTICLE; BREATHING MUSCLE; CERVICAL SPINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EXERCISE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FLEXOR MUSCLE; FORCED EXPIRATORY VOLUME; GRIP STRENGTH; HUMAN; INFLAMMATION; INSPIRATORY CAPACITY; KNEE; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; HAND STRENGTH; INHALATION; LUNG; MIDDLE AGED; MUSCLE ISOMETRIC CONTRACTION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HAND STRENGTH; HUMANS; INFLAMMATION MEDIATORS; INHALATION; ISOMETRIC CONTRACTION; LUNG; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84961207566     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9838-z     Document Type: Article

References (34)

1. Watz H, Waschki B, Boehme C et al (2007) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med 29:653–659
2. Gea J, Casadevall C, Pascual S et al (2012) Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 6:75–90
3. Hopkinson NS, Tennant RC, Dayer MJ et al (2007) A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 13:8–25
4. Gea J, Orozco-Levi M, Barreiro E, Ferrer A et al (2001) Structural and functional changes in the skeletal muscles of COPD patients: the “compartments” theory. Monaldi Arch Chest Dis 56:214–224
5. Swallow EB, Reyes D, Hopkinson NS et al (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62:115–120
6. Takeda K, Kawasaki Y, Yoshida K et al (2013) The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 8:347–351
7. Seger JY, Westing SH, Hanson M et al (1988) A new dynamometer measuring concentric and eccentric muscle strength in accelerated, decelerated, or isokinetic movements. Validity and reproducibility. Eur J Appl Physiol Occup Physiol 57:526–533
8. Ritti-Dias RM, Basyches M, Câmara L et al (2010) Test-retest reliability of isokinetic strength and endurance tests in patients with intermittent claudication. Vasc Med 15:275–278
9. Pleguezuelos E, Pérez ME, Guirao L et al (2013) Effects of whole body vibration training in patients with severe chronic obstructive pulmonary disease. Respirology 18:1028–1034
10. Chiu TT, Lam TH, Hedley AJ (2002) Maximal isometric muscle strength of the cervical spine in healthy volunteers. Clin Rehabil 16:772–779
11. Peolsson A, Hedlund R, Oberg B (2001) Intra- and inter-tester reliability and reference values for hand strength. J Rehabil Med 33:36–41
12. American Thoracic Society ATS Statement (2002) Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
13. Miravitlles M, Marin A, Monsó E et al (2010) Colour of sputum is a marker of bacterial colonization in COPD. Respir Res 11:58
14. Agustí A, Edwards LD, Rennard SI et al (2012) Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7:e374–e383
15. Evans RA, Kaplovitch E, Beauchamp MK et al (2015) Is quadriceps endurance reduced in COPD? A systematic review. Chest 147:673–684
16. Pitta F, Troosters T, Spruit MA et al (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:972–977
17. Hunt T, Madigan S, Williams MT et al (2014) Use of time in people with chronic obstructive pulmonary disease—a systematic review. Int J Chron Obstruct Pulmon Dis 12:1377–1388
18. Spector SA, Simard CP, Fournier M et al (1982) Architectural alterations of rat hind-limb skeletal muscles immobilized at different lengths. Exp Neurol 76:94–110
19. Williams PE (1998) Effect of intermittent stretch on immobilised muscle. Ann Rheum Dis 47:1014–1016
20. Coutinho EL, Gomes ARS, França CN et al (2004) Effect of passive stretching on the immobilized soleus muscle fibre morphology. Braz J Med Biol Res 37:1853–1861
21. Boyle R, Pompeiano O (1980) Responses of vestibulospinal neuronsto sinusoidal rotation of neck. J Neurophysiol 44:633–649
22. Heijdra YF, Pinto-Plata V, Frants R et al (2003) Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 124:75–82
23. Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980
24. Shah S, Nahar P, Vaidya S et al (2013) Upper limb muscle strength and endurance in chronic obstructive pulmonary disease. Indian J Med Res 138:492–496
25. García-Río F, Miravitlles M, Soriano JB et al (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11:63
26. Yende S, Waterer GW, Tolley EA et al (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well-functioning elderly subjects. Thorax 61:10–16
27. Gagnon P, Lemire BB, Dubé A et al (2014) Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respir Res 15:4
28. Barreiro E, Schols AM, Polkey MI et al (2008) ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100–107
29. Gan WQ, Man SF, Senthilselvan A et al (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580
30. Stockley RA (2009) Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 25:1235–1245
31. Gatta D, Aliprandi G, Pini L et al (2011) Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Eur Rev Med Pharmacol Sci 15:1068–1073
32. Garcia-Rio F, Lores V, Mediano O et al (2009) Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 180:506–512
33. Rossi A, Aisanov ZR, Avdeev S et al (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109:785–802
34. Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868